Standard BioTools Inc. Common Stock (LAB)
LABORATORY ANALYTICAL INSTRUMENTS
- Headquarters
- United States
- Employees
- 389
- Market Cap
- $351M
About Standard BioTools Inc. Common Stock
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.
SentiSense also tracks daily options readings for Standard BioTools Inc. Common Stock: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Standard BioTools Inc. Common Stock stock analysis, sentiment tracking, and market intelligence on SentiSense.